Twitter | Search | |
Bristol-Myers Squibb
Global Specialty Care BioPharma
4,698
Tweets
1,031
Following
109,367
Followers
Tweets
Bristol-Myers Squibb 4h
Immuno-oncology is a rapidly advancing area of cancer research, but only 1/4 Americans know about it.
Reply Retweet Like
Bristol-Myers Squibb Jun 25
Replying to @brianne_ogilvie
Thanks for letting us know. We will send you a direct message. Please ensure you follow us.
Reply Retweet Like
Bristol-Myers Squibb Jun 25
Replying to @WalzSue
Thanks for letting us know. We will send you a direct message. Please ensure you follow us.
Reply Retweet Like
Bristol-Myers Squibb Jun 24
: Extended 4-yr data in patients with to be presented at
Reply Retweet Like
Bristol-Myers Squibb Jun 24
nearly two-thirds of pediatric is non-Hodgkin? Learn more about pediatric :
Reply Retweet Like
Bristol-Myers Squibb Jun 24
Today, we’re presenting data on patients with Hodgkin & children with chronic myelogenous at
Reply Retweet Like
Bristol-Myers Squibb retweeted
PhRMA Jun 23
Explore genomics in VR with scientists like Mike from
Reply Retweet Like
Bristol-Myers Squibb Jun 23
There are a handful of risk factors for - we list them here:
Reply Retweet Like
Bristol-Myers Squibb Jun 23
Adam and Michael always had a special connection through their work. See how that connection runs even deeper now.
Reply Retweet Like
Bristol-Myers Squibb Jun 23
is committed to researching additional treatment options in pediatric cancers. Here’s why:
Reply Retweet Like
Bristol-Myers Squibb Jun 23
Join the fight against cancer with & raise your flag to show support for someone you love
Reply Retweet Like
Bristol-Myers Squibb Jun 22
Replying to @SupremeDickhead
Thanks for reaching out. To best address your comment, we will send you a private message. Please ensure you follow us.
Reply Retweet Like
Bristol-Myers Squibb Jun 22
is the most common type of . Find out more:
Reply Retweet Like
Bristol-Myers Squibb Jun 22
See how we’ve built a diverse pipeline through strategic business development: .
Reply Retweet Like
Bristol-Myers Squibb Jun 22
is the 13th most common cancer worldwide? RT to raise the awareness:
Reply Retweet Like
Bristol-Myers Squibb Jun 22
Looking forward to engaging on the topic of outcomes-based contracts at .
Reply Retweet Like
Bristol-Myers Squibb Jun 22
We’re presenting chronic myeloid , Hodgkin , & data at .
Reply Retweet Like
Bristol-Myers Squibb Jun 22
Innovative treatments gave Chris back his health, and the ability to be there for his children.
Reply Retweet Like
Bristol-Myers Squibb Jun 22
We’re proud to support for the first World Q&A Day.
Reply Retweet Like
Bristol-Myers Squibb Jun 22
Cancer affects many people’s lives, and our employees are no exception.
Reply Retweet Like